Post Conference Perspectives

Reactions and commentary on breaking clinical and health economic data presented at top conferences and their impact on practice and policy.

May 12th 2021AMCP Post-Conference Perspectives: Chronic Kidney Disease (CKD)

Robert Toto, MD, reviews key takeaways from the 2021 Academy of Managed Care Pharmacy meeting regarding healthcare resource utilization for patients with chronic kidney disease (CKD).

March 10th 2021Post Conference Perspective: Immune Checkpoint Inhibitors in Advanced and Metastatic Urothelial Carcinoma

Petros Grivas, MD, PhD, reviews emerging data from the 2021 ASCO GU Virtual Symposium on the role of immune checkpoint inhibitors for the treatment of advanced and metastatic urothelial carcinoma.

January 22nd 2021ASH 2020 Post Conference Perspectives: Updates in Multiple Myeloma

An expert in the field of multiple myeloma discusses key data releases from ASH 2020.

January 11th 2021AHA Post Conference Perspectives: Emerging Therapies in Hypertrophic Cardiomyopathy (HCM)

An expert in the management of hypertrophic cardiomyopathy discusses the burden of disease, existing treatment options, unmet needs, and explores data from an emerging class of agents, myosin inhibitors.

January 8th 2021ID Week 2020: Updates in HIV

Infectious disease expert discusses key data releases from ID Week 2020 within the field of HIV care.

January 21st 2020The Changing Treatment Landscape of B Cell Malignancies

December 19th 2019Navigating the Complex Treatment Landscape of Multiple Myeloma in Transplant Eligible Patients

December 27th 2018Perspective Role of Therapy for Multiple Myeloma

<1 2

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions